These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37913780)

  • 21. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
    Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
    Bassler D; Plavka R; Shinwell ES; Hallman M; Jarreau PH; Carnielli V; Van den Anker JN; Meisner C; Engel C; Schwab M; Halliday HL; Poets CF;
    N Engl J Med; 2015 Oct; 373(16):1497-506. PubMed ID: 26465983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids.
    Travers CP; Carlo WA; McDonald SA; Das A; Bell EF; Ambalavanan N; Jobe AH; Goldberg RN; D'Angio CT; Stoll BJ; Shankaran S; Laptook AR; Schmidt B; Walsh MC; Sánchez PJ; Ball MB; Hale EC; Newman NS; Higgins RD;
    Am J Obstet Gynecol; 2018 Jan; 218(1):130.e1-130.e13. PubMed ID: 29138031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial.
    Kribs A; Roll C; Göpel W; Wieg C; Groneck P; Laux R; Teig N; Hoehn T; Böhm W; Welzing L; Vochem M; Hoppenz M; Bührer C; Mehler K; Stützer H; Franklin J; Stöhr A; Herting E; Roth B;
    JAMA Pediatr; 2015 Aug; 169(8):723-30. PubMed ID: 26053341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
    Isayama T; Iwami H; McDonald S; Beyene J
    JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study.
    Yeh TF; Lin HC; Chang CH; Wu TS; Su BH; Li TC; Pyati S; Tsai CH
    Pediatrics; 2008 May; 121(5):e1310-8. PubMed ID: 18426851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review shows that using surfactant a number of times or as a vehicle for budesonide may reduce the risk of bronchopulmonary dysplasia.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Daoud P; Zupan V; Moreau F; Guilhoto I; Rouabah M; Alexandre C; Saliba E; Storme L; Patkai J; Pomedio M; Hamon I
    Acta Paediatr; 2018 Jul; 107(7):1140-1144. PubMed ID: 29193276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inositol in preterm infants at risk for or having respiratory distress syndrome.
    Howlett A; Ohlsson A; Plakkal N
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
    Rigo V; Lefebvre C; Broux I
    Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic versus Early Rescue Surfactant Treatment in Preterm Infants Born at Less than 30 Weeks Gestation or with Birth Weight Less than or Equal 1,250 Grams.
    Chun J; Sung SI; Ho YH; Kim J; Park GY; Yoon SA; Ahn SY; Chang YS; Park WS
    J Korean Med Sci; 2017 Aug; 32(8):1288-1294. PubMed ID: 28665065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis.
    Zhang ZQ; Zhong Y; Huang XM; Du LZ
    BMC Pulm Med; 2017 Dec; 17(1):207. PubMed ID: 29246209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of intratracheal administration of surfactant and budesonide combination in the prevention of bronchopulmonary dysplasia.
    Gharehbaghi MM; Mhallei M; Ganji S; Yasrebinia S
    J Res Med Sci; 2021; 26():31. PubMed ID: 34345242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal high flow therapy for primary respiratory support in preterm infants.
    Hodgson KA; Wilkinson D; De Paoli AG; Manley BJ
    Cochrane Database Syst Rev; 2023 May; 5(5):CD006405. PubMed ID: 37144837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.